FDAFDA · Food and drugs·Recall number D-1375-2020
Brimonidine Tartrate Opthalmic Solution 0.2%, 15 mL bottle, Rx only, Manufactured for: Somerset Therapeutics, LLC Hollywood, FL 33024. Made in India. NDC 70069-233-01
Published July 15, 2020 · Recall initiated: June 4, 2020
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specification: There is a slow leaching process from the product label on the bottle which may impact the product over the shelf life.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- BRIMONIDINE TARTRATE
- Manufacturer
- SOMERSET THERAPEUTICS LLC
- Distributor
- Nationwide
- UPC
- 0370069231012
- Lot
- Lot #s BRM13W9001, BRM13W9002, BRM13W9003, EXP Dec. 2020: BRM13W9004, EXP Apr. 2021.
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.